LEVELS – A Whole New Level cover image

#283 - Brain health explained: Insulin resistance, biomarkers, and Alzheimer’s risk | Dr. David Perlmutter & Mike Haney

LEVELS – A Whole New Level

00:00

Promising Drug Classes Beyond Amyloid

Mike asks about exciting drugs; Perlmutter discusses antidiabetics, metformin, GLP-1s, and repurposing choices for patients.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app